Internal Medicine, Nephrology · Denver, CO
NPI
1457469058
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
919 Jasmine St
Denver, CO, 80220
Phone (303) 991-0993
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
81 services
Medicare patients, 2024
11
Average age 70
Drug cost, 2024
$353K
81 prescriptions
Company payments, 2025
$20K
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Laura A Kooienga prescribed most often to Medicare patients was Filspari (Sparsentan), with 19 prescriptions and refills. In total Laura A Kooienga wrote 81 Medicare prescriptions that cost $353K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Filspari Sparsentan | 19 | 19 | Under 11 | $335K |
| Furosemide Generic | 16 | 30 | Under 11 | $121 |
| Lisinopril Generic | 15 | 21 | Under 11 | $108 |
Brand drugs: 35 claims; generic drugs: 46 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura A Kooienga $20K ($20K in general payments such as food, travel and fees) from 10 companies. The largest payer was Novartis Pharmaceuticals Corporation with $15K.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 19 | $15K |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 5 | $5,110 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $209 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $83.65 |
| Calliditas Therapeutics US Inc. | 1 | $35.12 |
| Ardelyx, Inc. ARDX | 1 | $35.04 |
| Amgen Inc. AMGN | 1 | $30.39 |
| Travere Therapeutics, Inc. TVTX | 2 | $26.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.